Market Tracker

12/09 5:16pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

38.77
Delayed Data
As of 4:09pm ET
 +0.52 / +1.36%
Today’s Change
36.58
Today|||52-Week Range
55.01
-24.28%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Biotech & Pharma ETFs to Suffer in 2017 Too?
Dec 08 / Zacks.com - Paid Partner Content
5 Secret Santa ETFs & Stocks for Your Portfolio
Dec 02 / Zacks.com - Paid Partner Content

Performance

1 month+0.23% 3 years-0.04%
3 months-15.18% 5 years+12.93%
1 year-24.34% Since inception+11.35%
Data through 12/09/2016

Quote Details

Previous close$38.25
Open day’s range38.45 – 39.15
Net asset value (NAV)38.28 (12/08/2016)
Daily volume466,661
Average volume (3 months)198,748
Data as of 4:09pm ET, 12/09/2016

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+12.93%+20.19%
Expense Gross exp ratio0.35%1.31%
Risk 5 year sharpe ratio0.691.11
Net assets$485.3M$2.9B
Average market cap$9.1B$31.6B
Average P/E20.518.6
Dividend / Share--0.26%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
HZNP Horizon Pharma PLC5.79%
BMY Bristol-Myers Squibb5.12%
ZTS Zoetis Inc5.05%
MRK Merck4.94%
PRGO Perrigo Company PLC4.91%
PFE Pfizer4.76%
JNJ Johnson & Johnson4.75%
MYL Mylan NV4.63%
MDCO Medicines Co4.62%
JAZZ Jazz Pharmaceuticals PLC4.43%